2 years ago
BKNG
AnalystsEdward WooEdward Woo's Stock Forecasts
AnalystsEdward Woo
Analyst Ranking
Top 18%
#906 out of 5096 analysts
Average Return
+3.65%
Win Rate
40%84 out of 209
Risk vs Reward
Poor
Good
Edward Woo's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Streamex CorpSTEX | +740.82% | $0.53 | $4.49 | 2025-04-20 - 2025-11-07 | Buy |
Aim Immunotech IncAIM | +670.64% | $0.22 | $1.68 | 2024-12-09 - 2025-11-07 | Buy |
Aim Immunotech IncAIM | +595.40% | $0.35 | $2.42 | 2024-09-02 - 2025-09-02 | Buy |
Quantum Computing IncQUBT | +593.18% | $0.88 | $6.10 | 2023-11-23 - 2024-11-22 | Buy |
Quantum Computing IncQUBT | +383.46% | $2.66 | $12.86 | 2024-11-12 - 2025-11-07 | Buy |
Edward Woo Analyst Color
Get additional color on Edward Woo's coverage of popular stocks
Edward Woo's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Nrx Pharmaceuticals IncNRXP | 6 | Buy | $47.00 | +1,818.37% | Maintains | 10 days ago |
Knightscope IncKSCP | 4 | Buy | $27.00 | +526.45% | Maintains | a month ago |
Intrusion IncINTZ | 5 | Buy | $12.00 | +618.56% | Maintains | a month ago |
Aemetis IncAMTX | 4 | Buy | $21.00 | +900.00% | Maintains | a month ago |
Genasys IncGNSS | 4 | Buy | $5.75 | +141.60% | Maintains | a month ago |
Plus Therapeutics IncPSTV | 5 | Buy | $21.00 | +3,788.89% | Maintains | a month ago |
Lucid Diagnostics IncLUCD | 7 | Buy | $8.00 | +640.74% | Maintains | a month ago |
Pavmed IncPAVM | 7 | Buy | $20.00 | +6,072.84% | Maintains | a month ago |
Aim Immunotech IncAIM | 3 | Buy | $24.00 | +1,328.57% | Maintains | a month ago |
Society Pass IncorporatedSOPA | 6 | Buy | $18.00 | +928.57% | Maintains | a month ago |
Banzai International IncBNZI | 6 | Buy | $30.00 | +1,604.55% | Maintains | a month ago |
Quantum Computing IncQUBT | 5 | Buy | $40.00 | +211.04% | Maintains | a month ago |
Surgepays IncSURG | 8 | Buy | $9.50 | +294.19% | Maintains | a month ago |
Allarity Therapeutics IncALLR | 2 | Buy | $9.25 | +704.35% | Maintains | a month ago |
Alzamend Neuro IncALZN | 6 | Buy | $42.00 | +1,664.71% | Maintains | a month ago |
Aytu Biopharma IncAYTU | 2 | Buy | $12.50 | +515.76% | Maintains | a month ago |
Maison Solutions IncMSS | 2 | Buy | $4.25 | +738.26% | Maintains | 2 months ago |
Duos Technologies Group IncDUOT | 7 | Buy | $11.50 | +15.93% | Maintains | 2 months ago |
Myomo IncMYO | 5 | Buy | $10.50 | +1,129.51% | Maintains | 2 months ago |
Endra Life Sciences IncNDRA | 4 | Buy | $38.00 | +627.27% | Maintains | 2 months ago |
Gri Bio IncGRI | 4 | Buy | $35.00 | +1,983.33% | Maintains | 2 months ago |
Sintx Technologies IncSINT | 3 | Buy | $25.00 | +664.53% | Maintains | 2 months ago |
Outlook Therapeutics IncOTLK | 5 | Buy | $8.00 | +572.27% | Maintains | 2 months ago |
Atossa Therapeutics IncATOS | 6 | Buy | $7.75 | +843.97% | Maintains | 2 months ago |
TravelzooTZOO | 5 | Buy | $26.00 | +246.67% | Maintains | 2 months ago |
Igc Pharma IncIGC | 6 | Buy | $4.50 | +1,122.83% | Maintains | 2 months ago |
Renovorx IncRNXT | 6 | Buy | $12.00 | +1,147.40% | Maintains | 2 months ago |
Cingulate IncCING | 3 | Buy | $62.00 | +1,562.20% | Maintains | 3 months ago |
Phunware IncPHUN | 6 | Buy | $12.50 | +448.25% | Maintains | 5 months ago |
Streamex CorpSTEX | 4 | Buy | $10.00 | +122.72% | Maintains | 5 months ago |
Ton Strategy CoTONX | 4 | Buy | $62.00 | +1,778.79% | Maintains | 5 months ago |
Envoy Medical IncCOCH | 5 | Buy | $9.50 | +1,253.28% | Maintains | 5 months ago |
Pro Dex IncPDEX | 4 | Buy | $56.00 | +80.94% | Maintains | 5 months ago |
Groupon IncGRPN | 8 | Buy | $19.00 | +5.85% | Maintains | 8 months ago |
Daxor CorpDXR | 3 | Buy | $25.00 | +92.90% | Maintains | 8 months ago |
Electronic Arts IncEA | 2 | Buy | $160.00 | -20.24% | Maintains | 8 months ago |
Take Two Interactive Software IncTTWO | 11 | Buy | $270.00 | +16.38% | Maintains | 8 months ago |
Datavault Ai IncDVLT | 3 | Buy | $11.00 | +550.89% | Maintains | a year ago |
Biolase IncBIOL | 2 | Buy | $2.00 | N/A | Maintains | a year ago |
Mira Pharmaceuticals IncMIRA | 1 | Buy | $11.00 | N/A | Initiates Coverage On | a year ago |
Jakks Pacific IncJAKK | 1 | Buy | $38.00 | N/A | Maintains | 2 years ago |
Booking Holdings IncBKNG | 2 | Buy | $3,900.00 | N/A | Maintains | 2 years ago |
Expedia Group IncEXPE | 1 | Buy | $168.00 | N/A | Maintains | 2 years ago |
Tripadvisor IncTRIP | 1 | Buy | $30.00 | N/A | Maintains | 2 years ago |
Algorhythm Holdings IncRIME | 1 | Buy | $4.00 | N/A | Initiates Coverage On | 2 years ago |
Heartsciences IncHSCS | 1 | Buy | $330.00 | N/A | Initiates Coverage On | 3 years ago |
Vivos Therapeutics IncVVOS | 1 | Buy | $62.50 | N/A | Initiates Coverage On | 3 years ago |
Autoweb IncAUTO | 1 | Hold | $0.39 | N/A | Downgrades | 3 years ago |
Guardion Health Sciences IncGHSI | 1 | Buy | $37.50 | N/A | Initiates Coverage On | 3 years ago |
Blackboxstocks IncBLBX | 1 | Buy | $24.00 | N/A | Initiates Coverage On | 3 years ago |
Novabay Pharmaceuticals IncNBY | 3 | Buy | $4,900.00 | N/A | Maintains | 3 years ago |
Activision Blizzard IncATVI | 3 | Buy | $95.00 | N/A | Maintains | 4 years ago |
Gamestop CorpGME | 8 | Sell | $5.75 | N/A | Maintains | 4 years ago |
Blue Nile IncNILE1 | 1 | Buy | $6.00 | N/A | Initiates Coverage On | 4 years ago |
Imac Holdings IncBACK | 1 | Buy | N/A | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.